B A Mahal1, M-H Chen2, C L Bennett3, M W Kattan4, O Sartor5, K Stein6, A V D'Amico7, P L Nguyen7. 1. Harvard Medical School, Boston, MA, USA. 2. Department of Statistics, University of Connecticut, Storrs, CT, USA. 3. South Carolina College of Pharmacy, Hollings Cancer Center, Charleston, SC, USA. 4. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. 5. Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. 6. Novartis, East Hanover, NJ, USA. 7. Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: To examine the impact of race on treatment regret among men with recurrent prostate cancer after surgery or radiation. METHODS: The prospective Comprehensive, Observational, Multicenter, Prostate Adenocarcinoma (COMPARE) registry was used to study a cohort of 484 men with biochemically recurrent prostate cancer after radical prostatectomy, external beam radiation or brachytherapy. Multivariable logistic regression was used to model the association between race and treatment regret and to determine whether there was an interaction between race and sexual problems after treatment with regards to treatment regret. RESULTS: Black men (N=78) were significantly more likely to have treatment regret when compared with non-black men (N=406; 21.8% versus 12.6%) on univariable analysis (odds ratio (OR) 1.94; 95% confidence interval 1.05-3.56; P=0.03). On multivariable analysis, black race trended towards but was no longer significantly associated with an increase in treatment regret (adjusted OR (AOR) 1.84 (0.95-3.58); P=0.071). There was an interaction between race and sexual problems after treatment (Pinteraction=0.02) such that among those without sexual problems, black men had more treatment regret than non-black men (26.7% versus 8.4%: AOR 4.68 (1.73-12.63); P=0.002), whereas among those with sexual problems, there was no difference in treatment regret between black and non-black men (18.8% versus 17.3%: AOR 1.04 (0.44-2.46); P=0.93). CONCLUSIONS: Among men with recurrent prostate cancer after surgery or radiation, black men were nearly twice as likely to experience treatment regret. Treating physicians should ensure that patients are fully apprised of the pros and cons of all treatment options to reduce the risk of subsequent regret.
BACKGROUND: To examine the impact of race on treatment regret among men with recurrent prostate cancer after surgery or radiation. METHODS: The prospective Comprehensive, Observational, Multicenter, Prostate Adenocarcinoma (COMPARE) registry was used to study a cohort of 484 men with biochemically recurrent prostate cancer after radical prostatectomy, external beam radiation or brachytherapy. Multivariable logistic regression was used to model the association between race and treatment regret and to determine whether there was an interaction between race and sexual problems after treatment with regards to treatment regret. RESULTS: Black men (N=78) were significantly more likely to have treatment regret when compared with non-black men (N=406; 21.8% versus 12.6%) on univariable analysis (odds ratio (OR) 1.94; 95% confidence interval 1.05-3.56; P=0.03). On multivariable analysis, black race trended towards but was no longer significantly associated with an increase in treatment regret (adjusted OR (AOR) 1.84 (0.95-3.58); P=0.071). There was an interaction between race and sexual problems after treatment (Pinteraction=0.02) such that among those without sexual problems, black men had more treatment regret than non-black men (26.7% versus 8.4%: AOR 4.68 (1.73-12.63); P=0.002), whereas among those with sexual problems, there was no difference in treatment regret between black and non-black men (18.8% versus 17.3%: AOR 1.04 (0.44-2.46); P=0.93). CONCLUSIONS: Among men with recurrent prostate cancer after surgery or radiation, black men were nearly twice as likely to experience treatment regret. Treating physicians should ensure that patients are fully apprised of the pros and cons of all treatment options to reduce the risk of subsequent regret.
Authors: V Diane Woods; Susanne B Montgomery; Juan Carlos Belliard; Johnny Ramirez-Johnson; Colwick M Wilson Journal: Cancer Control Date: 2004 Nov-Dec Impact factor: 3.302
Authors: Clement K Gwede; Julio Pow-Sang; John Seigne; Randy Heysek; Mohamed Helal; Kristin Shade; Alan Cantor; Paul B Jacobsen Journal: Cancer Date: 2005-10-01 Impact factor: 6.860
Authors: Shemille A Collingwood; Russell B McBride; Michael Leapman; Adele R Hobbs; Young Suk Kwon; Kristian D Stensland; Rebecca M Schwartz; Matthew E Pollard; David B Samadi Journal: Urol Oncol Date: 2014-01-09 Impact factor: 3.498
Authors: Paul L Nguyen; Ming-Hui Chen; Karen E Hoffman; Ronald C Chen; Jim C Hu; Charles L Bennett; Michael W Kattan; Oliver Sartor; Karen Stein; Anthony V D'Amico Journal: BJU Int Date: 2011-11-15 Impact factor: 5.588
Authors: Chanita Hughes Halbert; Benita Weathers; Ernestine Delmoor; Brandon Mahler; James Coyne; Hayley S Thompson; Thomas Ten Have; David Vaughn; S Bruce Malkowicz; David Lee Journal: Cancer Date: 2009-06-01 Impact factor: 6.860
Authors: Ahsan M Arozullah; Paul R Yarnold; Charles L Bennett; Robert C Soltysik; Michael S Wolf; Rosario M Ferreira; Shoou-Yih D Lee; Stacey Costello; Adil Shakir; Caroline Denwood; Fred B Bryant; Terry Davis Journal: Med Care Date: 2007-11 Impact factor: 2.983
Authors: Padraig Warde; Malcolm Mason; Keyue Ding; Peter Kirkbride; Michael Brundage; Richard Cowan; Mary Gospodarowicz; Karen Sanders; Edmund Kostashuk; Greg Swanson; Jim Barber; Andrea Hiltz; Mahesh K B Parmar; Jinka Sathya; John Anderson; Charles Hayter; John Hetherington; Matthew R Sydes; Wendy Parulekar Journal: Lancet Date: 2011-11-02 Impact factor: 79.321
Authors: Pearman D Parker; Sue P Heiney; Swann Arp Adams; Daniela B Friedman; Robin M Dawson Journal: Appl Nurs Res Date: 2020-07-23 Impact factor: 2.257
Authors: Donna L Berry; Fangxin Hong; Traci M Blonquist; Barbara Halpenny; Niya Xiong; Christopher P Filson; Viraj A Master; Martin G Sanda; Peter Chang; Gary W Chien; Randy A Jones; Tracey L Krupski; Seth Wolpin; Leslie Wilson; Julia H Hayes; Quoc-Dien Trinh; Mitchell Sokoloff Journal: Urol Oncol Date: 2021-01-19 Impact factor: 2.954
Authors: Seul Ki Choi; Jessica S Seel; Brooks Yelton; Susan E Steck; Douglas P McCormick; Johnny Payne; Anthony Minter; Elizabeth K Deutchki; James R Hébert; Daniela B Friedman Journal: Am J Mens Health Date: 2018-04-12